Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
31.4M
-
Shares change
-
+1.14M
-
Total reported value, excl. options
-
$1.8B
-
Value change
-
+$73.8M
-
Put/Call ratio
-
0.69
-
Number of buys
-
124
-
Number of sells
-
-110
-
Price
-
$57.47
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q2 2023
266 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q2 2023.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.4M shares
of 46.4M outstanding shares and own 67.6% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.09M shares), FEDERATED HERMES, INC. (3.43M shares), VANGUARD GROUP INC (2.77M shares), DIMENSIONAL FUND ADVISORS LP (1.93M shares), NEUBERGER BERMAN GROUP LLC (1.49M shares), STATE STREET CORP (1.39M shares), FULLER & THALER ASSET MANAGEMENT, INC. (1.28M shares), GEODE CAPITAL MANAGEMENT, LLC (780K shares), NORTHERN TRUST CORP (635K shares), and MORGAN STANLEY (567K shares).
This table shows the top 239 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.